| MORPHOSYS AG O.N. | 105.50 / -0.47% |
| Date/Time | 11/20 / 17:35 |
| Chg. / Chg.(%) | -0.50 / -0.47% |
| Bid | - |
| Ask | - |
| Open | 105.90 |
| Previous Close | 106.00 |
| High | 107.70 |
| Low | 104.60 |
| Volume [EUR] | 17,096,744.00 |
| Volume [Units] | 161,519 |
| Price fixings | 1366 |
| ISIN | DE0006632003 |
| Security | MOR |
| Exchange | Xetra |
| Type | Stock |
| Exchange | Last | Volume | |
|---|---|---|---|
| Xetra | 105.50 |  |
161,519 |
| London Inter.. | 105.80 | |
32,075 |
| Cboe Europe .. | 104.90 | |
22,656 |
| Turquoise | 105.05 | |
15,858 |
| TradeGate | 104.400 | |
12,511 |
| Cboe Europe .. | 104.90 | |
8,633 |
| Stuttgart | 104.700 | |
5,321 |
| Frankfurt | 104.9000 | |
1,608 |
| Nasdaq Other.. | 117.0000 | |
200 |
| München | 105.00 |  |
50 |
| Hamburg | 106.80 | |
35 |
| Vienna Globa.. | 104.90 | |
16 |
| Hannover | 105.50 | |
0 |
| Berlin | 105.20 | |
0 |
| Düsseldorf | 105.30 | |
0 |
| SIX Swiss Ex.. | 102.00 | |
|
| Lang & Schwa.. | 104.700 | |
|
| gettex | 105.000 | |
|
| EUREX | Options | ||
News
- MOR106 clinical development in atopic dermatitis stopped for futility
10/28/2019 / 21:45 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:02 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:01 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:04 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:01 - GlobeNewswire
Real-time